BARD1 and pulmonary fibrosis: We suggest that BARD1 might act as downstream activator of epithelial cell apoptosis and fibroblast proliferation and therefore might present a strong candidate target molecule for the treatment of lung fibrosis and possibly other diseases in which fibro-proliferation is a feature.